APPAREILS
– gÉNomique
& TRANSCRIPTOMIQUE
Signature Q100
The platform has the Signature Q100 (Olink), which enables the quantification of 92 targeted protein biomarkers (multiplex immunoassay, Proximity Extension Assay or PEA technology) in matrices such as serum or plasma (1µl), cell lysate, etc.
Access to this technology is by project service and specific quotation. You order your targeted panels, prepare your samples and we take care of the expert assessment and quality control validation, then send you the data in .xls format.
You can find the Olink link here and the principle of PEA® technology here
Centre de Recherches contre le Cancer de Toulouse (Oncopole)
Toulouse - FR
CRCT-Oncopole Follow 1,433 1,279
Compte officiel du Centre de Recherches en Cancérologie de Toulouse
;
🇬🇧Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. ImPact team @CordelierPierre article from @crctoncopole published in @CommsBio
➡️https://www.crct-inserm.fr/en/targeting-the-energy-production-process-in-pancreatic-cancer-cells-which-relies-on-an-enzyme-called-cytidine-deaminase-could-make-these-cells-more-vulnerable/
Nous contacter
+33 5 82 74 15 75
Nous rejoindre ?
